Cargando…
Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report
Patient: Male, 70-year-old Final Diagnosis: Drug induced hepatopathy • gangrenous cholecystitis • IgG4 related sclerosing cholangitis • systemic IgG4 related disease Symptoms: Abdominal pain • jaundice Medication: — Clinical Procedure: Computed tomography • magnetic resonance cholangiopancreatograph...
Autores principales: | Gummlich, Benjamin Peter Michael, Hosseini, Ali Seif Amir, Schwörer, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745840/ https://www.ncbi.nlm.nih.gov/pubmed/36476942 http://dx.doi.org/10.12659/AJCR.938272 |
Ejemplares similares
-
IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019) -
IgG4-Related Sclerosing Cholangitis Mimicking Cholangiocarcinoma
por: Minh Thong, Pham, et al.
Publicado: (2021) -
IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma
por: Ng, Wei R, et al.
Publicado: (2023) -
Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA)
por: Park, Jae Keun, et al.
Publicado: (2022) -
IgG4-related sclerosing cholangitis: liver biopsy findings
por: Ryu, Han Suk, et al.
Publicado: (2011)